CRESCO LABS INC. SUB. VTGCRESCO LABS INC. SUB. VTGCRESCO LABS INC. SUB. VTG

CRESCO LABS INC. SUB. VTG

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
−0.02EUR
Revenue estimate
‪169.78 M‬EUR
Market capitalization
‪840.75 M‬EUR
−0.4928EUR
‪−161.94 M‬EUR
‪711.24 M‬EUR
‪316.42 M‬
Beta (1Y)
1.50

About CRESCO LABS INC.

CEO
Charles Bachtell
Headquarters
Chicago
Employees (FY)
‪2.76 K‬
Founded
1990
FIGI
BBG00PXPR0X6
Cresco Labs Inc. engages in cultivating medical grade cannabis, manufacturing medical products derived from cannabis cultivation, and distributing such products to medical or adult use consumers. It focuses on regulatory compliance while working to develop condition-specific strains of cannabis and non-invasive delivery methods. The company was founded by Charles Bachtel, Joseph Caltabiano, Dominic Sergi, Rob Sampson, and Brian McCormack on July 6, 1990 and is headquartered in Chicago, IL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange CRESCO LABS INC. SUB. VTG stocks are traded under the ticker 6CQ.
CRESCO LABS INC. SUB. VTG is going to release the next earnings report on May 15, 2024. Keep track of upcoming events with our Earnings Calendar.
6CQ earnings for the last quarter are −0.27 EUR per share, whereas the estimation was −0.04 EUR resulting in a −616.97% surprise. The estimated earnings for the next quarter are −0.02 EUR per share. See more details about CRESCO LABS INC. SUB. VTG earnings.
CRESCO LABS INC. SUB. VTG revenue for the last quarter amounts to ‪180.68 M‬ EUR despite the estimated figure of ‪173.69 M‬ EUR. In the next quarter revenue is expected to reach ‪164.61 M‬ EUR.
Yes, you can track CRESCO LABS INC. SUB. VTG financials in yearly and quarterly reports right on TradingView.
6CQ net income for the last quarter is ‪2.45 M‬ EUR, while the quarter before that showed ‪−107.94 M‬ EUR of net income which accounts for 102.27% change. Track more CRESCO LABS INC. SUB. VTG financial stats to get the full picture.
No, 6CQ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 6CQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CRESCO LABS INC. SUB. VTG stock right from TradingView charts — choose your broker and connect to your account.
6CQ reached its all-time high on Feb 10, 2021 with the price of 14.7900 EUR, and its all-time low was 0.9106 EUR and was reached on Aug 25, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 29, 2024, the company has ‪2.76 K‬ employees. See our rating of the largest employees — is CRESCO LABS INC. SUB. VTG on this list?
We've gathered analysts' opinions on CRESCO LABS INC. SUB. VTG future price: according to them, 6CQ price has a max estimate of 12.16 EUR and a min estimate of 1.87 EUR. Read a more detailed CRESCO LABS INC. SUB. VTG forecast: see what analysts think of CRESCO LABS INC. SUB. VTG and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CRESCO LABS INC. SUB. VTG EBITDA is ‪122.70 M‬ EUR, and current EBITDA margin is 17.19%. See more stats in CRESCO LABS INC. SUB. VTG financial statements.